John Taylor

John Taylor Email and Phone Number

Entrepreneur in Residence @ Formation Bio
Raleigh, NC, US
John Taylor's Location
Durham, North Carolina, United States, United States
About John Taylor

A strategic and collaborative leader with an entrepreneurial focus and track record of success. Demonstrated leadership, strategic, transactional, and team-building skills creating value for biopharma companies. Operational expertise selecting product portfolios and setting development strategy, interfacing with investors and partners for fund-raising, business development and M&A, and leading high performing teams to execute. • Development experience with small molecules, biologics, peptides, and drug delivery technologies across numerous therapeutic areas• Executive leadership and fund-raising, gaining access to nearly $150 million in financing • Pharma and biotech product and technology partnerships• Buy-side and sell-side deal expertise, multiple geographies• M&A transactions, including 2 go-public deals• Significant expertise in rare diseasesI particularly enjoy the art of turning science into products with the potential to transform the standard of care, and leading teams to make those products a business that can offer hope patients deserve and the return investors require.

John Taylor's Current Company Details
Formation Bio

Formation Bio

View
Entrepreneur in Residence
Raleigh, NC, US
John Taylor Work Experience Details
  • Formation Bio
    Entrepreneur In Residence
    Formation Bio
    Raleigh, Nc, Us
  • Aceragen
    Co-Founder, Chief Executive Officer & Director
    Aceragen 2021 - 2024
    Durham, North Carolina, Us
    Clinical-stage therapeutics company focused on late-stage rare disease portfolio in pulmonary and rheumatology. Devised and executed corporate strategy resulting in funding, product and merger transactions, including gaining a public listing via reverse merger. Led senior team in building an amazing 30-person development and operations team. Pre-Nasdaq, company’s access to funding was ~$95 million.
  • Belhaven Biopharma
    Board Member
    Belhaven Biopharma Jan 2022 - Dec 2023
    Belhaven is a clinical-stage drug development company advancing novel products using nasal delivery.
  • North Carolina Biotechnology Center
    Entrepreneur In Residence
    North Carolina Biotechnology Center 2018 - 2022
    Research Triangle Park, Nc, Us
    Assisted NCBC staff in creating EIR program to add strength to investment team and provide strategic guidance to therapeutic and drug development companies. Rejoined team in 2024.
  • Spyryx Biosciences
    Co-Founder, Chief Executive Officer & Director
    Spyryx Biosciences 2013 - 2018
    Durham, Nc, Us
    Clinical-stage biotech company launched from UNC-Chapel Hill to develop ENaC modulators as novel therapies for lung complications associated with cystic fibrosis. Funded by Canaan, Hatteras, and 5AM, with an additional development award from the CF Foundation.
  • Synageva Biopharma Corp.
    Vice President, Corporate Development
    Synageva Biopharma Corp. 2009 - 2013
    Lexington, Massachusetts, Us
    Therapeutic protein company focused on lysosomal storage disorders and other rare/ultra-rare diseases. Lead product, Kanuma, approved for lysosomal acid lipase deficiency (LALD) in US and EU. Led corporate and business development function sourcing deals and supporting product development portfolio. Major partnering transactions with Mitsubishi Tanabe; played a key role in executing reverse merger with Trimeris.
  • Javelin Pharmaceuticals, Inc.
    Vice President, Business Development
    Javelin Pharmaceuticals, Inc. Apr 2008 - Sep 2009
    Cambridge, Massachusetts, Us
    Pharmaceutical company developing and commercializing products for post-operative pain and cancer-breakthrough pain. Led business development and strategic partnering function, major EU product transaction with Therabel.
  • Eurand Pharma
    Director, Business Development
    Eurand Pharma 2003 - 2008
    Specialty pharma commercializing oral drug delivery platform. Senior member of US BD team, sourced 8 development deals in 5 years including 3 of the company's largest.
  • Sarnoff Corporation
    Director, Business Development
    Sarnoff Corporation 2001 - 2002
    Us
  • Amersham Pharmacia Biotech
    Licensing Product Manager
    Amersham Pharmacia Biotech 1998 - 2001
  • Biowhittaker
    Bioprocessing Specialist
    Biowhittaker 1994 - 1998

John Taylor Education Details

  • The Wharton School
    The Wharton School
    Technology Management
  • Clemson University
    Clemson University
    Biological Sciences

Frequently Asked Questions about John Taylor

What company does John Taylor work for?

John Taylor works for Formation Bio

What is John Taylor's role at the current company?

John Taylor's current role is Entrepreneur in Residence.

What schools did John Taylor attend?

John Taylor attended The Wharton School, Clemson University.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.